Share Name Share Symbol Market Type Share ISIN Share Description
Phibro Animal S LSE:PAHC London Ordinary Share USU694051058 COM SHS USD0.0001 (REGS)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +$0.00 +0.00% $5.225 $0.00 $0.00 - - - 0 06:40:20
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
- - - - 0.00

Phibro Animal S Share Discussion Threads

Showing 1 to 2 of 25 messages
Chat Pages: 1
RNS Number : 6024U Phibro Animal Health Corporation 16 May 2008 For additional information contact: Richard G. Johnson, Chief Financial Officer, +1-201-329-7300 or PHIBRO ANIMAL HEALTH CORPORATION REPORTS 22% REVENUE GROWTH FOR ITS MARCH 2008 FISCAL THIRD QUARTER RIDGEFIELD PARK, New Jersey, May 16, 2008 - Phibro Animal Health Corporation ('PAHC' or the 'Company') announced its operating results for its fiscal third quarter ending March 31, 2008. Quarterly sales of $132 million increased $24 million, or 22%, led by volume increases in the Animal Health & Nutrition business. Adjusted ebitda (earnings before interest, taxes and depreciation and amortization) of $11.7 million increased $2.5 million, or 25%, in line with sales growth. Adjusted ebitda excludes $15.2 million of one-time costs related to the recent equity transactions. After including the one-time costs and interest and income taxes, the Company reported a $12.3 million net loss for the quarter. Animal Health & Nutrition Sales of $108.5 million increased $22.3 million or 26%, due to volume growth in most product lines and markets and also due to increased pricing to offset raw material cost increases. Adjusted ebitda of $13.1 million increased $1.4 million, or 12%, as the volume increases were partially offset by higher manufacturing costs due to the strengthening of the Brazilian Real against the U.S. dollar and by increased sales force headcount. Performance Products Distribution sales of $15.3 million increased $1.8 million, or 13%, primarily from volume growth. Adjusted ebitda of $3.6 million improved $0.4 million on the sales increase. Industrial Chemicals sales of $8.5 million were slightly below last year. The Company began marketing its new Sustain™ wood preservative product during the quarter. Increased sales of the new product were offset by reductions in legacy product lines. Adjusted ebitda was a loss of $0.6 million, but an improvement of $1.1 million compared with last year, due to the improved product mix and legal expenses incurred last year in defense of intellectual property related to the wood preservative market. For further information, the Company's quarterly report is available on our website in the Investor Relations section at Forward-Looking Statements This announcement contains forward-looking statements, including statements regarding management's expectations and beliefs regarding the future results or performance of the Company. Because these statements apply to future events, they are subject to risks and uncertainties. When used in this announcement, the words 'anticipate,' 'believe,' 'estimate,' 'expect,' 'expectation,' 'project' and 'intend' and similar expressions are intended to identify such forward-looking statements. Our actual results could differ materially from those projected in the forward-looking statements. Additionally, you should not consider past results to be an indication of our future performance. We do not intend to update any of the forward-looking statements after the date of this announcement to conform these statements to actual results, to changes in management's expectations or otherwise, except as may be required by law. About The Company PAHC is a diversified global manufacturer and marketer of a broad range of animal health and nutrition products to the poultry, swine and cattle markets. PAHC is also a manufacturer and marketer of performance products for the ethanol, wood preservation and personal care industries. For more information, please visit For more information: Phibro Animal Health Corporation Richard Johnson, Chief Financial Officer +1 201 329 7300 Panmure Gordon (UK) Limited Andrew Godber Rakesh Sharma +44 (0) 20 7459 3600
Summary of Phibro Animal Health Corporation securities Phibro Animal Health Corporation common shares are currently traded on AIM only. Shares in issue Percentage Total issued share capital 69,000,000 Shares not in public hands 68,910,000 99.9% Major shareholdings as at 4 April 2008: Name No. of ordinary shares Percentage BFI Co., LLC 48,300,000 70.0% 3i Quoted Private Equity Limited 20,600,000 29.9%
Chat Pages: 1
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:33 V: D:20180122 02:45:41